Zentalis Pharmaceuticals, Inc. (ZNTL)
3.11
+0.03
(+0.97%)
USD |
NASDAQ |
Sep 18, 16:00
3.11
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Market Cap : 222.89M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 220.74M |
| September 16, 2026 | 222.17M |
| September 15, 2026 | 224.32M |
| September 14, 2026 | 250.84M |
| September 11, 2026 | 251.56M |
| September 10, 2026 | 257.29M |
| September 09, 2026 | 272.34M |
| September 08, 2026 | 288.82M |
| September 04, 2026 | 285.96M |
| September 03, 2026 | 294.56M |
| September 02, 2026 | 270.19M |
| September 01, 2026 | 265.89M |
| August 31, 2026 | 269.47M |
| August 28, 2026 | 272.34M |
| August 27, 2026 | 278.07M |
| August 26, 2026 | 278.79M |
| August 25, 2026 | 278.07M |
| August 24, 2026 | 269.47M |
| August 21, 2026 | 274.13M |
| August 20, 2026 | 275.21M |
| August 19, 2026 | 273.77M |
| August 18, 2026 | 263.74M |
| August 17, 2026 | 265.53M |
| August 14, 2026 | 255.14M |
| August 13, 2026 | 297.42M |
| Date | Value |
|---|---|
| August 12, 2026 | 307.46M |
| August 11, 2026 | 294.56M |
| August 10, 2026 | 297.42M |
| August 07, 2026 | 302.44M |
| August 06, 2026 | 358.34M |
| August 05, 2026 | 354.76M |
| August 04, 2026 | 349.74M |
| August 03, 2026 | 330.88M |
| July 31, 2026 | 337.28M |
| July 30, 2026 | 350.09M |
| July 29, 2026 | 332.30M |
| July 28, 2026 | 328.74M |
| July 27, 2026 | 320.91M |
| July 24, 2026 | 308.11M |
| July 23, 2026 | 316.64M |
| July 22, 2026 | 320.20M |
| July 21, 2026 | 356.49M |
| July 20, 2026 | 356.49M |
| July 17, 2026 | 363.61M |
| July 16, 2026 | 325.18M |
| July 15, 2026 | 340.13M |
| July 14, 2026 | 339.41M |
| July 13, 2026 | 328.74M |
| July 10, 2026 | 347.24M |
| July 09, 2026 | 334.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ARS Pharmaceuticals, Inc. | 408.69M |
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 276.89M |
| Savara, Inc. | 1.104B |
Market Cap Related Metrics
| Price to Book Value | 1.552 |
| Price | 3.11 |
| Earnings Yield | -62.94% |